Salivary mucins of patients with cystic fibrosis. Composition and susceptibility to degradation by salivary glycosidases.
D003550:Cystic Fibrosis / Q000201:enzymology / Q000378:metabolism*; D005643:Fucose / Q000032:analysis; D005696:Galactosidases / Q000378:metabolism; D005959:Glucosidases / Q000378:metabolism; D006026:Glycoside Hydrolases / Q000378:metabolism* / Q000494:pharmacology; D006595:Hexosamines / Q000032:analysis; D006601:Hexoses / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009077:Mucins / Q000032:analysis*; D009438:Neuraminic Acids / Q000032:analysis; D009439:Neuraminidase / Q000378:metabolism; D011485:Protein Binding; D012463:Saliva / Q000032:analysis* / Q000201:enzymology
D006595:Hexosamines; D006601:Hexoses; D009077:Mucins; D009438:Neuraminic Acids; D005643:Fucose; D005696:Galactosidases; D005959:Glucosidases; D006026:Glycoside Hydrolases; D009439:Neuraminidase